Intestinal metabolites predict treatment resistance of patients with depression and anxiety
Abstract Background The impact of the gut microbiota on neuropsychiatric disorders has gained much attention in recent years; however, comprehensive data on the relationship between the gut microbiome and its metabolites and resistance to treatment for depression and anxiety is lacking. Here, we inv...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Gut Pathogens |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13099-024-00601-3 |